Medistim ASA (OSL:MEDI)

Revenue by Geography

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2011 - 2020
Americas Revenue	276.34M	237.16M	Log In	Log In	Log In	Upgrade
APAC Revenue	80.93M	65.46M	Log In	Log In	Log In	Upgrade
EMEA Revenue	177.39M	170.16M	Log In	Log In	Log In	Upgrade
Third Party Products Revenue	99.85M	89.82M	Log In	Log In	Log In	Upgrade

Revenue by Geography 2

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2011 - 2020
USA Revenue	-	Log In	Log In	Log In	Upgrade
Asia Revenue	-	Log In	Log In	Log In	Upgrade
Europe Revenue	-	Log In	Log In	Log In	Upgrade
Rest Of The World Revenue	-	Log In	Log In	Log In	Upgrade

Revenue Breakdown

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2011 - 2020
PPP and Lease Revenue - Flow Procedures (PPP/Card Based)	54.84M	61.34M	Log In	Log In	Log In	Upgrade
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based)	40.71M	39.50M	Log In	Log In	Log In	Upgrade
Capital Sales - Flow Systems	62.76M	55.22M	Log In	Log In	Log In	Upgrade
Capital Sales - Flow and Imaging Systems	99.27M	69.17M	Log In	Log In	Log In	Upgrade
Capital Sales - Flow Probes	257.93M	231.47M	Log In	Log In	Log In	Upgrade
Capital Sales - Imaging Probes	19.17M	16.08M	Log In	Log In	Log In	Upgrade
Total Own Products Revenue	534.67M	472.78M	Log In	Log In	Log In	Upgrade
Third Party Products Revenue	99.85M	89.82M	Log In	Log In	Log In	Upgrade

Revenue Breakdown 2

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2011 - 2020
Third Party Products Revenue	99.85M	89.82M	Log In	Log In	Log In	Upgrade
Coronary Surgery Revenue	421.36M	379.05M	Log In	Log In	Log In	Upgrade
Vascular Surgery Revenue	113.31M	93.72M	Log In	Log In	Log In	Upgrade
Other Product Revenue	-	-	Log In	Log In	Log In	Upgrade

Revenue by Geography 3

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2011 - 2020
Third Party Products Revenue	99.85M	89.82M	Log In	Log In	Log In	Upgrade

Key Performance Indicators

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2011 - 2020
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) Units Sold	21.94K	23.54K	Log In	Log In	Log In	Upgrade
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) Units Sold	8.12K	7.48K	Log In	Log In	Log In	Upgrade
PPP and Lease Revenue - Flow Systems (PPP/Lease) Units Sold	-	4.00	Log In	Log In	Log In	Upgrade
PPP and Lease Revenue - Flow and Imaging Systems (PPP/Lease) Units Sold	3.00	5.00	Log In	Log In	Log In	Upgrade
Capital Sales - Flow Systems Units Sold	129.00	116.00	Log In	Log In	Log In	Upgrade
Capital Sales - Flow and Imaging Systems Units Sold	78.00	66.00	Log In	Log In	Log In	Upgrade
Capital Sales - Flow Probes Units Sold	10.46K	9.63K	Log In	Log In	Log In	Upgrade
Capital Sales - Imaging Probes Units Sold	152.00	132.00	Log In	Log In	Log In	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai.